Delivery Order SPE2DB22D2009-SPE2DB26FL5WE
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,758.62 delivery order contract is for the supply of Chloraseptic Max 15-10 mg lozenges, a medical product used for pain relief. The contract has a firm fixed-price pricing type and an ultimate completion date of May 24, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,707.30 to AmerisourceBergen Drug Corp for Chloraseptic Sore Throat Lozenges (18-count packages). Issued on August 6, 2025, with an ultimate completion date of August 7, 2025, this firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,449.39, is for the supply of Chloraseptic Max 15-10 mg lozenge products. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global...
- The Defense Logistics Agency awarded a delivery order valued at $1,744.20 to AmerisourceBergen Drug Corp for Chloraseptic Sore Throat Lozenges (18-count) on September 11, 2025, with completion targeted for September 12, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a single-line pharmaceutical product delivery under the...
- The Defense Logistics Agency awarded a delivery order valued at $5,855.84 to AmerisourceBergen Drug Corp for Chloraseptic Sore Throat Lozenges (18 count) on July 15, 2025, with completion scheduled for July 16, 2025. This firm fixed price contract, which received no set-aside designation, was competitively awarded and performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a...
- This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Chloraseptic Max 15-10 mg Lozenges. The $2,054.66 firm-fixed-price contract has an ultimate completion date of August 7, 2024. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December 2025, which serves as the primary vehicle for providing a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,221.75 to AmerisourceBergen Drug Corp for Chloraseptic Sore Throat Lozenges (18 count). The contract is a firm fixed-price delivery order with no set-aside designation, executed on August 13, 2025, with an ultimate completion date of August 14, 2025. Performance will take place at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a task order issued under AmerisourceBergen...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,185.93 firm fixed-price delivery order is for the provision of Chloraseptic Max 15-10 mg lozenges, which are medical products used for pain relief. The contract has an ultimate completion date of October 23, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $1,031.50 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Chloraseptic Max 15-10 mg lozenges. The contract has a completion date of February 7, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical with a potential value of $999,999,999.00 and a performance period through...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,141.82, is for the delivery of CHLORASEPTIC MAX 15-10 MG LOZ 15S, a medical product. The contract has a completion date of June 17, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract with DLA Troop Support...
- SPE2DB22D2009Indefinite Delivery Contract
- SPE2DB22D2009-SPE2DB26FL5WEDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 17, 2025, for Chloraseptic Max 15-10 mg lozenges (15-count packages) with a ceiling value of $1,800.03 and a completion date of October 20, 2025. This is a firm fixed price, non-set-aside contract executed as a delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract represents routine pharmaceutical supply fulfillment to support military and federal healthcare operations, with performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania facility. This award is part of AmerisourceBergen's extensive portfolio supporting federal medical procurement needs. The company maintains a $999,999,999 prime indefinite delivery vehicle with the DLA Troop Support Medical (designation SPE2DX) running through December 2026, which provides comprehensive pharmaceutical and medical supply support to military healthcare programs globally. AmerisourceBergen's federal contract awards consistently reflect competitively awarded delivery orders ranging from small-value transactions to substantial orders, demonstrating the company's established capability as a critical vendor for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 10/17/25 |